PharmAust Ltd Receives World Wide Attention., page-21

Again , you state the Market has not cottoned on??? my opinion is this is due to lackluster announcements that don't receive cut through, the below announcement should have put the re-formulation issue to bed... Your previous post showing 20 sites the last announcement was published on ,,, then reflected a decrease in the SP...
Monepantel reformulation successfully increases dose and improves taste 30 January 2018 – Perth, Australia: PharmAust Limited (ASXAA) has successfully identified a reformulation method that can be used to prepare monepantel for clinical trial. In collaboration with BRI Pharmaceutical Research, PharmAust has shown that micronisation of monepantel successfully meets the company’s minimal requirements for dosing, taste masking and oral bioavailability.